Skip to content

Effect of Transcutaneous Auricular Vagus Nerve Stimulation on the Incidence of Postoperative Delirium in Elderly Patients with Diabetes Undergoing Orthopedic Surgery

Effect of Transcutaneous Auricular Vagus Nerve Stimulation on the Incidence of Postoperative Delirium in Elderly Patients with Diabetes Undergoing Orthopedic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126326
Enrollment
Unknown
Registered
2026-06-08
Start date
2026-06-15
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium (POD)

Interventions

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) Group:Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
Sham Stimulation Group:Sham Stimulation

Sponsors

Wuxi No.2 People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age = 65 years, meeting the definition of elderly patients; 2. Previously diagnosed with type 2 diabetes, with blood glucose basically under stable control; 3. Planned to undergo elective orthopedic surgery under general anesthesia (such as hip replacement, fracture internal fixation, etc., with an expected surgery duration of 1-5 hours); 4. Meets the PACU admission criteria postoperatively; 5. Patient and family are informed and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Pre-existing cognitive impairment or cognitive dysfunction before surgery; 2.Preoperative sleep disorders; 3.Severe hearing impairment or external ear diseases (e.g., severe infection or malformation) that preclude auricular stimulation; 4.Implanted cardiac pacemaker or severe cardiac arrhythmias (e.g., high-grade atrioventricular block, sick sinus syndrome); 5.Requirement for prolonged sedation with endotracheal intubation during the perioperative period (making delirium assessment infeasible), or anticipated ICU stay >24 hours; 6.Any other conditions judged by the investigators to potentially interfere with the intervention or outcome assessment;

Design outcomes

Primary

MeasureTime frame
Postoperative Delirium (POD);

Secondary

MeasureTime frame
Inflammatory Stress Markers;Sleep Quality;Postoperative Pain and Adverse Events;Perioperative Glycemic Control;Anxiety and depression (HADS);

Countries

China

Contacts

Public ContactDongxiao Huang

Wuxi No.2 People’s Hospital

hdxss88@sina.com+86 5109612369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026